Persistent mutation burden drives sustained anti-tumor immune responses.
Nat Med
; 29(2): 440-449, 2023 02.
Article
in En
| MEDLINE
| ID: mdl-36702947
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Non-Small-Cell Lung
/
Lung Neoplasms
/
Melanoma
Limits:
Humans
Language:
En
Journal:
Nat Med
Journal subject:
BIOLOGIA MOLECULAR
/
MEDICINA
Year:
2023
Document type:
Article
Affiliation country:
Estados Unidos
Country of publication:
Estados Unidos